Evolving intellectual property landscape for AI-driven innovations in the biomedical sector: opportunities in stable IP regime for shared success.

IF 3 Q2 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE Frontiers in Artificial Intelligence Pub Date : 2024-09-17 eCollection Date: 2024-01-01 DOI:10.3389/frai.2024.1372161
Abhijit Poddar, S R Rao
{"title":"Evolving intellectual property landscape for AI-driven innovations in the biomedical sector: opportunities in stable IP regime for shared success.","authors":"Abhijit Poddar, S R Rao","doi":"10.3389/frai.2024.1372161","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial Intelligence (AI) has revolutionized the biomedical sector in advanced diagnosis, treatment, and personalized medicine. While these AI-driven innovations promise vast benefits for patients and service providers, they also raise complex intellectual property (IP) challenges due to the inherent nature of AI technology. In this review, we discussed the multifaceted impact of AI on IP within the biomedical sector, exploring implications in areas like drug research and discovery, personalized medicine, and medical diagnostics. We dissect critical issues surrounding AI inventorship, patent and copyright protection for AI-generated works, data ownership, and licensing. To provide context, we analyzed the current IP legislative landscape in the United States, EU, China, and India, highlighting convergences, divergences, and precedent-setting cases relevant to the biomedical sector. Recognizing the need for harmonization, we reviewed current developments and discussed a way forward. We advocate for a collaborative approach, convening policymakers, clinicians, researchers, industry players, legal professionals, and patient advocates to navigate this dynamic landscape. It will create a stable IP regime and unlock the full potential of AI for enhanced healthcare delivery and improved patient outcomes.</p>","PeriodicalId":33315,"journal":{"name":"Frontiers in Artificial Intelligence","volume":"7 ","pages":"1372161"},"PeriodicalIF":3.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11442499/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Artificial Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frai.2024.1372161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial Intelligence (AI) has revolutionized the biomedical sector in advanced diagnosis, treatment, and personalized medicine. While these AI-driven innovations promise vast benefits for patients and service providers, they also raise complex intellectual property (IP) challenges due to the inherent nature of AI technology. In this review, we discussed the multifaceted impact of AI on IP within the biomedical sector, exploring implications in areas like drug research and discovery, personalized medicine, and medical diagnostics. We dissect critical issues surrounding AI inventorship, patent and copyright protection for AI-generated works, data ownership, and licensing. To provide context, we analyzed the current IP legislative landscape in the United States, EU, China, and India, highlighting convergences, divergences, and precedent-setting cases relevant to the biomedical sector. Recognizing the need for harmonization, we reviewed current developments and discussed a way forward. We advocate for a collaborative approach, convening policymakers, clinicians, researchers, industry players, legal professionals, and patient advocates to navigate this dynamic landscape. It will create a stable IP regime and unlock the full potential of AI for enhanced healthcare delivery and improved patient outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物医学领域人工智能驱动创新的知识产权格局演变:稳定的知识产权制度为共享成功带来的机遇。
人工智能(AI)为生物医学领域的先进诊断、治疗和个性化医疗带来了革命性的变化。虽然这些人工智能驱动的创新有望为患者和服务提供商带来巨大利益,但由于人工智能技术的固有特性,它们也带来了复杂的知识产权(IP)挑战。在本综述中,我们讨论了人工智能对生物医学领域知识产权的多方面影响,探讨了药物研究与发现、个性化医疗和医疗诊断等领域的影响。我们剖析了围绕人工智能发明权、人工智能作品的专利和版权保护、数据所有权和许可等方面的关键问题。为了提供背景资料,我们分析了美国、欧盟、中国和印度目前的知识产权立法情况,重点介绍了与生物医学领域相关的趋同、分歧和开创先例的案例。认识到协调的必要性,我们回顾了当前的发展情况,并讨论了前进的道路。我们主张采取合作的方式,召集政策制定者、临床医生、研究人员、行业参与者、法律专业人士和患者权益倡导者,共同驾驭这一充满活力的局面。这将建立一个稳定的知识产权制度,充分释放人工智能的潜力,从而提高医疗服务质量,改善患者治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
2.50%
发文量
272
审稿时长
13 weeks
期刊最新文献
Advancing smart city factories: enhancing industrial mechanical operations via deep learning techniques. Inpainting of damaged temple murals using edge- and line-guided diffusion patch GAN. Catalyzing IVF outcome prediction: exploring advanced machine learning paradigms for enhanced success rate prognostication. Predicting patient reported outcome measures: a scoping review for the artificial intelligence-guided patient preference predictor. A generative AI-driven interactive listening assessment task.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1